EUVIMEDSkopri EUVIMED
Crossref

Albuterol Or Levalbuterol For The Treatment Of Asthma

The Internet Journal of Asthma, Allergy and Immunology · 2004

DOI: 10.5580/1f4f ↗

At a glance

Journal article in The Internet Journal of Asthma, Allergy and Immunology, 2004. Cited 2 times so far (Crossref).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Albuterol is the most commonly used β2-agonist currently used in the treatment of asthma and COPD. Until recently, it was only available as a racemate, a 50:50 mixture of the dextro ((S)-albuterol) and levo ((R)-albuterol) rotatory forms. Previously, it was felt that the (S)-albuterol enantiomer was minimally active (distomer) relative to the (R)-albuterol enantiomer (eutomer). It is expensive to separate the racemic mixture of albuterol into its' individual enantiomers. If the racemate bronchodilates with less cost, the distomer was viewed as incidental isomeric ballast or filler. The general consensus has been that there was no need or incentive to increase the expense of production in synthesizing (R)-albuterol as an individual drug if the racemate could serve the same function at double the dose with no adverse effects. This view, however, has been subject to challenge and may not be correct. The human 2 receptor has a greater than 90-fold affinity for (R)-albuterol relative to (S)-albuterol (1). This suggests that activation of β2 receptors occurs primarily from R-albuterol. This is consistent with pharmacodynamic studies (2,3). The distomer, aside from causing a small (possibly random or chiral inversion related) increase in potassium concentration had absolutely no systemic effects in 12 healthy volunteers given individual single oral doses of (R), (R,S), or (S)-albuterol (2). Inhaled doses of (R), (R,S), or (S)-albuterol in 15 healthy volunteers in a single day study gave no systemic effects with S-albuterol (3). These findings in humans are consistent with the concept that (S)-albuterol is a filler in racemic albuterol that is just going along for the ride.

Cite

APA

(2004). Albuterol Or Levalbuterol For The Treatment Of Asthma. The Internet Journal of Asthma, Allergy and Immunology. https://doi.org/10.5580/1f4f

Vancouver

Albuterol Or Levalbuterol For The Treatment Of Asthma. The Internet Journal of Asthma, Allergy and Immunology. 2004. doi:10.5580/1f4f

BibTeX
@article{euvimed2004,
  title = {Albuterol Or Levalbuterol For The Treatment Of Asthma},
  journal = {The Internet Journal of Asthma, Allergy and Immunology},
  year = {2004},
  doi = {10.5580/1f4f}
}
Start for free →